Jackson M R, Belott T P, Dickason T, Kaiser W J, Modrall J G, Valentine R J, Clagett G P
Department of Surgery, University of Texas Southwestern Medical Center, Ft Bliss, TX, USA.
J Vasc Surg. 2000 Sep;32(3):498-504; 504-5. doi: 10.1067/mva.2000.108634.
Although there are numerous reports comparing saphenous vein (SV) and polytetrafluoroethylene (PTFE) with respect to the patency rates for femoropopliteal bypass grafts, the clinical consequences of failed grafts are not as well described. This study compares the outcomes of failed SV and PTFE grafts with a specific emphasis on the degree of acute limb ischemia caused by graft occlusion.
Over a 6-year period, 718 infrainguinal revascularization procedures were performed, of which 189 were femoropopliteal bypass grafts (SV, 108; PTFE, 81). Society for Vascular Surgery/International Society for Cardiovascular Surgery (SVS/ISCVS) standardized runoff scores were calculated from preoperative arteriograms. Clinical categories of acute limb ischemia resulting from graft occlusion were graded according to SVS/ISCVS standards (I, viable; II, threatened; III, irreversible). Primary graft patency and limb salvage rates at 48 months were calculated according to the Kaplan-Meier method.
Patients were well matched for age, sex, and comorbidities. Chronic critical ischemia was the operative indication in most cases (SV, 82%; PTFE, 80%; P =.85). Runoff scores and preoperative ankle-brachial index measurements were similar for the two groups (SV, 6.0 +/- 2.5 [SD] and 0.51 +/- 0.29; PTFE, 5.3 +/- 2.8 and 0.45 +/- 0.20; P =.06 and P =.12). The distal anastomosis was made below the knee in 60% of SV grafts and 16% of PTFE grafts (P <.001). Grade II ischemia was more likely to occur after occlusion of PTFE grafts (78%) than after occlusion of SV grafts (21%; P =.001). Emergency revascularization after graft occlusion was required for 28% of PTFE failures but only 3% of SV graft failures (P <.001). Primary graft patency at 48 months was 58% for SV grafts and 32% for PTFE grafts (P =.008). Limb salvage was achieved in 81% of SV grafts but only 56% of PTFE grafts (P =.019).
Patients undergoing femoropopliteal bypass grafting with PTFE are at greater risk of ischemic complications from graft occlusion and more frequently require emergency limb revascularization as a result of graft occlusion than patients receiving SV grafts. Graft patency and limb salvage are superior with SV in comparison with PTFE in patients undergoing femoropopliteal bypass grafting.
尽管有大量关于股腘动脉搭桥移植术中隐静脉(SV)和聚四氟乙烯(PTFE)通畅率比较的报告,但对于移植失败的临床后果描述较少。本研究比较了失败的SV和PTFE移植的结果,特别关注移植闭塞引起的急性肢体缺血程度。
在6年期间,共进行了718例腹股沟下血管重建手术,其中189例为股腘动脉搭桥移植(SV,108例;PTFE,81例)。根据术前血管造影计算血管外科学会/国际心血管外科学会(SVS/ISCVS)标准化流出评分。根据SVS/ISCVS标准对移植闭塞导致的急性肢体缺血临床类别进行分级(I级,存活;II级,濒危;III级,不可逆)。采用Kaplan-Meier法计算48个月时的原发性移植通畅率和肢体挽救率。
患者在年龄、性别和合并症方面匹配良好。大多数病例的手术指征为慢性严重缺血(SV,82%;PTFE,80%;P = 0.85)。两组的流出评分和术前踝肱指数测量结果相似(SV,6.0±2.5[标准差]和0.51±0.29;PTFE,5.3±2.8和0.45±0.20;P = 0.06和P = 0.12)。60%的SV移植和16%的PTFE移植在膝关节以下进行远端吻合(P < 0.001)。PTFE移植闭塞后发生II级缺血的可能性(78%)高于SV移植闭塞后(21%;P = 0.001)。28%的PTFE移植失败需要在移植闭塞后进行紧急血管重建,而SV移植失败仅为3%(P < 0.001)。SV移植48个月时的原发性移植通畅率为58%,PTFE移植为32%(P = 0.008)。81%的SV移植实现了肢体挽救,而PTFE移植仅为56%(P = 0.019)。
与接受SV移植的患者相比,接受PTFE股腘动脉搭桥移植的患者因移植闭塞发生缺血性并发症的风险更高,并且更频繁地需要因移植闭塞进行紧急肢体血管重建。在接受股腘动脉搭桥移植的患者中,与PTFE相比,SV的移植通畅率和肢体挽救效果更佳。